Roche, Ascletis in Chinese deal for HCV

Roche (SIX:ROG; OTCQX:RHHBY) granted Ascletis Pharmaceuticals Co. Ltd. (Chapel Hill, N.C.) exclusive, Chinese rights to the pharma's HCV compound danoprevir. Under the deal, Ascletis will fund develop...